Press release
Osteoporosis Drugs Market Development, Growth and Demand Forecast to 2020 by P&S Market Research
North America leads the osteoporosis drugs market, due to increasing investment on research and development in the region for innovation of advanced drugs, growing aging population and increasing occurrence of lifestyle related diseases. The Asia-Pacific osteoporosis drugs market is expected to grow with an exponential rate in the coming years. India and China are the growing with the highest rate in osteoporosis drugs market. The highest growth rate of the countries is, due to huge pool of patients, growing healthcare expenditure, increasing geriatric population, modifying lifestyles and rising appreciation of osteoporosis care.
Explore more about “Osteoporosis Drugs Market” at: www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market
Osteoporosis disease occurs due to reduced bone mineral density, which causes increased risk of fractures and fragile bones. Bone mineral density decreases naturally with age, thus aging population is facing high risks of osteoporosis disease. The decline in bone strength is only visible after the bone gets fractured. Most of the spine, hip and forearm fractures occur within aged people of 65 years and above. . The consumers having a family history of the osteoporosis disease are at intensified risk of the disease, since it is a heritable disease. Especially, the consumers from Asian and European origins have more risks of osteoporosis disease. One of the major procedures to build stronger muscle and bones is exercising regularly during the teenage years, which in turn leads to a lower risk of osteoporosis disease. The increasing trend of inactive lifestyle and obesity leads to growing prevalence of osteoporosis disease.
Request Table of Contents: www.psmarketresearch.com/market-analysis/Osteoporosis-Drugs-Market/toc-sample
The osteoporosis drugs market can be categorized on the basis of drug class into antiresorptive drugs and anabolic drugs. Antiresorptive drugs include RANKL antibodies, selective oestrogen receptor modulators, calcitonin salmon, cathepsin K inhibitors, bisphosphonates, binosto and protelos. Anabolic drugs include, blosozumab, human recombinant parathyroid hormones, BA-058, PTH (1-31) NH2, anti sclerostin monoclonal antibodies, preotact, ZT-034 and ZP-PTH.
Establishment of advanced drug classes with greater efficiency to overcome the risk of side effects and generics is the major factors driving the growth of osteoporosis drugs market to some extent. Complications and side effects of the osteoporosis drugs such as, nausea, irritable bowel syndrome and ulcers in stomach is affecting the growth of the osteoporosis drugs market to some extent. Strict regulatory standards such as, Phase IV investigations and patent expiries of drugs are the factors restraining growth of the osteoporosis drugs market.
Browse Other Related Report at: www.psmarketresearch.com/industry-report/healthcare
Some of the competitors in the osteoporosis drugs market are, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Merck & Co, Inc., F. Hoffmann La Roche Ltd., Novo Nordisk A/S, Actavis PLC, Novartis International AG, Amgen, Inc., and Pfizer, Inc.
About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.
Contact:
Abhishek
Executive – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: www.psmarketresearch.com
347 5th Ave. #1402- 210
New York City
United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Osteoporosis Drugs Market Development, Growth and Demand Forecast to 2020 by P&S Market Research here
News-ID: 373415 • Views: …
More Releases from P&S Market Research
Smart Cities Market Size, Revenue, Technology, Competitive Analysis, Growth Driv …
The global smart cities market is growing at a CAGR above 20% during 2018 - 2023 and will reach $2578.0 billion by 2023. Due to significant growth in automation technologies such as internet of things (IoT) and adoption of cloud based technologies, the global smart cities market is gaining huge traction. In addition, effective city asset management for public welfare, substantial operational cost savings, and automated public data generation applications…
Global Sports Food Market Expected to Witness 9.2% CAGR During 2016 – 2022
The global sports food market is expected to grow at a CAGR of 9.2% in terms of value during 2016 - 2022. Among the various types, the energy bars segment accounted for the largest share (71.5%) in the global sports food market in 2015.
Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/sports-food-market/report-sample
The manufacturers are trying to bring about products with the best blend of taste and healthy ingredients. They have started to…
Sports Nutrition Market by Type, Distribution Channel, Region, Growth and Demand …
The global sports nutrition market is expected to grow at a CAGR of 8.4% in terms of value during 2016 - 2022. Among the various types, the sports drinks segment accounted for largest share (61.4%) in the global sports nutrition market in 2015.
Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/sports-nutrition-market/report-sample
The increasing health concerns, such as obesity and awareness of physical appearances among all consumers groups is driving the demand for sports…
Orthopedic Trauma Devices Market Supply Chain Trends Mapping the Latest Technolo …
The global orthopedic trauma devices market is growing due to the increasing frequency of fractures, along with the growth of aging population. The advantageous features posed by orthopedic trauma devices, such as internal and external fixators to set a fracture, and in repositioning of bone fragments into their normal alignment are also driving the growth of the market worldwide. Furthermore, the internal fixators have reduced the hospital stays, reduced the…
More Releases for Osteoporosis
Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period?
The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024…
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate?
The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected…
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market
The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of…
Osteoporosis Drugs: The Complete Review
Medication for osteoporosis increases bone mineral density and reduces fracture risk. Some osteoporosis medications promote bone growth while others reduce bone loss.
The bones may begin to deteriorate as age more quickly than the body can heal them. The doctor could determine that people have osteoporosis if they have significant bone density loss.
To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market/report-sample
Although osteoporosis cannot be treated, it can be slowed down or…
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related…
